AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04286178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: ubiquinol
Description: Coenzyme Q10 (CoQ10, ubiquinol) will be taken at a dose of 10mg/kg/day divided into 2 daily doses with a daily maximum of 500mg. CoQ10 will be administered orally in 50mg softgels containing 50mg of ubiquinol (Active Q®), provided by Tishcon Corporation.
Study NCT04286178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: glucose tablet
Description: Creatine placebo will be in the form of a glucose tablet with identical appearance and taste to the active supplement. The number of tablets/day will be determined based on the dose of creatine required for each patient.
Study NCT04286178 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: gel capsule
Description: Ubiquinol placebo will be in the form of a gel capsule with identical appearance to the active supplement. The number of capsules/day will be determined based on the dose of ubiquinol required for each patient.
Study NCT04286178 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: Participants will be coached to hit 12,000 steps or 60 active minutes per day as logged by a FitBit (FitBit calculates active minutes as activities equivalent to moderate-to-vigorous physical activity (MVPA) done continuously for at least 10 minutes)
Study NCT04286178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will be coached to hit 12,000 steps or 60 active minutes per day as logged by a FitBit (FitBit calculates active minutes as activities equivalent to moderate-to-vigorous physical activity (MVPA) done continuously for at least 10 minutes)
Study NCT05780879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Venetoclax administered orally once daily on days 3-16.
Study NCT05780879 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FLAG or CLAG Protocol
Description: FLAG consists of daily infusions of Fludarabine (30mg/m2/day over 30 minutes) and Ara-C (2g/m2/day over 4 hours) for 5 days with daily subcutaneous injections of G-CSF until count recovery. Tbo-filgrastim will be administered as follows: WBC count >50,000 - 5mcg/kg; WBC count \<50,000 - hold Tbo-filgrastim. Given the national shortage of Fludarabine, Cladrabine (5mg/m2/day IV over 2 hours) has been substituted (CLAG) with similar toxicity profile.
Study NCT05911529 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Supportive conversations
Description: In the control intervention patients should also be given four sessions, in which no MI techniques take place. They will be carried out in the sense of supportive conversations (i. e. conver-sations that do not follow a specific psychotherapy concept).~Since we want to check whether the patients really benefit from the specific intervention and not from getting more speaking time, the patient in the control group will also be given four conver-sations. It is known that supportive conversations can have a certain effect on the well-being and recovery process of patients, as the therapeutic relationship, i.e. appreciation, attention and/or attention, is an important efficacy factor (e. g. Grawe, 1995).
Study NCT06546462 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Description: The active arm will receive osteopathic manipulative treatment which is a hands-on treatment modality use to treat a variety of health concerns.
Study NCT06546462 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Light touch arm
Description: Sham arm will receive a light touch sham treatment.
Study NCT05007964 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spatz4 Adjustable Balloon System
Description: The Spatz4 Adjustable Balloon System is designed to assist weight loss by partially filling the stomach and inducing satiety. The intragastrical balloon is implanted endoscopically for up to 12 months.
Study NCT06061692 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Tongxinluo Capsule
Description: 4 capsules/time, tid, p.o Duration of Treatment: 1 year (12 months)
Study NCT06061692 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tongxinluo Capsule
Description: 4 capsules/time, tid, p.o Duration of Treatment: 1 year (12 months)
Study NCT04686019 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Description: IMT and conventional neurorehabilitation - treatment as usual. The intervention group will add-on IMT sessions exercising at 30 % of MIP. MIP is measured by instructing the patient to perform five forceful inspirations against an occluded mouthpiece (Power Breath). The best score is multiplied by 0.3 to determine the resistance. IMT is performed with IMT Threshold flute with the calculated resistance. During the measurement with Power Breath the patient sits straight up and uses nose clip. The patient can receive help to hold the Power Breath if necessary.~One session of IMT with IMT threshold flute consists of 2 times 15 inspirations in normal breathing rhythm (5-10 min). Patients in the intervention group perform 2 sessions a day (morning and evening), training is performed prior to a meal, 7 days a week for 3 weeks.
Study NCT06322524 — intervention group
Intervention type: DEVICE
Intervention: Gamma sensory flicker
Description: participants were exposed to flicker stimulation through a light and sound device, the flicker was 40 Hz.
Study NCT06299228 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental Group
Description: Sensorimotor intervention, active range of motion, active assisted range of motion, strengthening
Study NCT06299228 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control Group
Description: Active range of motion, active assisted range of motion and strengthening
Study NCT04771351 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: COVI-AMG
Description: COVI-AMG is a fully human SARS-CoV-2 neutralizing monoclonal antibody (mAb)
Study NCT04771351 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Diluent solution
Study NCT04644341 — intervention group
Intervention type: COMBINATION_PRODUCT
Intervention: cardiovascular and respiratory systems monitoring
Description: only one group of individuals to observe the impact of COVID-19 on their cardiovascular and respiratory systems in long term.
Study NCT05493449 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: UHT Milk
Description: In this group of participants, UHT milk, 180 mL was provided and results were compared with control and flavored milk group
Study NCT05493449 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Flavored Milk
Description: In this group of participants, flavored milk, 180 mL was provided and results were compared with control and UHT group
Study NCT06137105 — intervention group
Intervention type: DRUG
Intervention: eltrombopag and romiplastim
Description: Group I: eltrombopag and romiplastim~Group II : recived corticosteroid.
Study NCT05325931 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: kalifilcon A Daily Disposable Multifocal
Description: kalifilcon A Daily Disposable Multifocal low add and high
Study NCT05325931 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: samfilcon A for Presbyopia
Description: Ultra for Presbyopia Low and High Add Contact Lenses
Study NCT04955431 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction
Description: Participants will be allowed \~4 hour sleep opportunity during the restricted night of sleep prior to reporting to lab for a simulated firefighting session.
Study NCT04955431 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Normal Sleep
Description: Participants will be allowed \~8 hour sleep opportunity the night of sleep prior to reporting to lab for a simulated firefighting session.
Study NCT05510206 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Leveling and alignment
Description: Polishing, Bonding of appliance, placement of the first arch wire for Super elastic NiTi group then the second wire after two months taking study model each month during the study For Smartarch Group placing experimental arch wire for 4 months , taking impression each month.~For both groups peri-apical X-Ray to lower anterior teeth is taken prior to treatment and 4 months later, also visual pain analogue scale is taken for 7 days after placing archwires
Study NCT05510206 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Leveling and alignment
Description: Polishing, Bonding of appliance, placement of the first arch wire for Super elastic NiTi group then the second wire after two months taking study model each month during the study For Smartarch Group placing experimental arch wire for 4 months , taking impression each month.~For both groups peri-apical X-Ray to lower anterior teeth is taken prior to treatment and 4 months later, also visual pain analogue scale is taken for 7 days after placing archwires
Study NCT05496322 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Non Invasive Blood Pressure Monitoring
Description: Continuous non-invasive arterial pressure monitoring
Study NCT04727437 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No treatment
Description: Withholding anticoagulation for at least 3 months.
Study NCT04727437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Warfarin
Description: anticoagulation drug given for at least 3 months.
Study NCT04727437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: direct oral anticoagulants
Description: anticoagulation drug given for at least 3 months.
Study NCT04727437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Low molecular weight heparin
Description: anticoagulation drug, subcutaneous injection given for at least 3 months.
Study NCT05496322 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Intermittent Non Invasive Blood Pressure Monitoring
Description: Intermittent non-invasive arterial pressure monitoring
Study NCT05739968 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care + oncology case manager (OCM) care
Description: Usual care + oncology case manager (OCM) care
Study NCT05739968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Multi-domains Active-living Program (MAP) with e-health enhanced intervention + usual care + oncology case manager (OCM) care
Description: Multi-domains Active-living Program (MAP) with e-health enhanced intervention + usual care + oncology case manager (OCM) care
Study NCT06611059 — intervention group
Intervention type: DEVICE
Intervention: PSG
Description: Two replicas of each scapula are made. The scapulae are drilled with a commercial guide and with an in-house guide separately
Study NCT05589519 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Partial rehabilitation using PEEK
Description: A 3-unit implant-supported fixed prosthesis using PEEK polymer in its composition delivered as definitive prosthesis for partial rehabilitation of edentulous jaws.
Study NCT05690373 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Probiotic effect on influenza vaccine response
Description: Seroconversion rate: the percentage of subjects achieving at least a 4-fold increase or an increase from >10 to 40 in Ab titre for seronegative subjects.
Study NCT06676501 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ExAblate
Description: Transcranial focused ultrasound thalamotomy
Study NCT06677398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Debriefing Method 1
Description: The researchers used a debriefing method that they chose after a virtual simulation
Study NCT06677398 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Debriefing Method VP
Description: The researchers used the debriefing method that virtual patient simulator presents
Study NCT06677398 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Debriefing Method 2
Description: The researchers used a debriefing method that they chose after a virtual simulation
Study NCT06677476 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mobile application training
Description: Researchers compiled literature information and used their expertise to create mobile application content. This content will be downloaded to mobile phones via mobile application software and participants will be trained.
Study NCT06192953 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Proprioceptive Stimulation
Description: Orthoses with a system of 12 stimulators producing mechanical oscillations are attached to the joints of the upper limbs (wrist, elbow and shoulder) or lower limb joints (ankle, knee, hip). These stimulators, which are all synchronized, deliver mechanical oscillations (FPS) that give the illusion of complex movements, while the patient is bedridden, neither moving nor producing effort.
Study NCT06251219 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PCR
Description: PCR test for EV71, CA16, CA10, or CA6
Study NCT03889600 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: REDD-CAT
Description: After obtaining informed consent from a participant and gathering baseline data, the study RA will send a flag in the EMR to notify the nurse care manager that a patient has enrolled in the REDD-CAT pilot. The nurse care manager will then incorporate the administration of the REDD-CAT to the patient as part of standard care discharge planning. He or she will utilize the REDD-CAT results report as a guideline for generating appropriate referrals to address unmet social needs identified.
Study NCT05727085 — intervention group
Intervention type: OTHER
Intervention: All pregnant women with a twin pregnancy and the offspring
Description: No intervention
Study NCT05223491 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: En Bloc resection
Description: Tumour is resected and removed from the bladder in one piece, if possible.
Study NCT05223491 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional TURB
Description: Tumour is resected piecemeal.
Study NCT05637437 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Peer supported diabetes self-care intervention
Description: Participants in the intervention group will attend a multi-faceted 8 weeks peer supported diabetes self-care intervention through digital communication.~* Weekly group video telephony meeting facilitated by trained peer supporters.~* Support and assistance through instant messaging services between peer supporters and participants.
Study NCT05637437 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Participants in the control group will receive the usual care of the hospital.
Study NCT05637437 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual care
Description: Participants in the control group will receive the usual care of the hospital.
Study NCT05294419 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: CVD Integrated Risk Test
Description: CVD IRT (IVD regulations with a software device)
Study NCT05069155 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Gamification
Description: Each participant signs a pre-commitment contract agreeing to try their best to achieve their daily step goal. Each week over the 12 week intervention period, participants are endowed 70 points (10/day). Participants are informed they will lose 10 points for each day the step goal is not met. Points are replenished at the start of the week. At the end of the week, if the participant has 40 points or more, he/she will advance one level, or drop one level if they have less than 40 points. The levels include: blue (lowest), bronze, silver, gold, platinum (highest). Each participant begins in the middle (silver). Each participant will also select a spouse, family member, or friend that they see often to serve as a supportive sponsor that receives a weekly email participants progress including points, game level, and average step countThis supportive sponsor will help to enhance social incentives to motivate the individual towards his or her goal.
Study NCT05032521 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: collection of biological data
Description: collection of biological data
Study NCT05032521 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: collection of biological data
Description: collection of biological data
Study NCT05032521 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: collection of demographic, ventilatory, cardiac echocardiography, arterial and venous gas data
Description: These data are usually measured continuously (monitoring of the resuscitation patient) and recorded on recorded on the resuscitation software.
Study NCT05032521 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: collection of demographic, ventilatory, cardiac echocardiography, arterial and venous gas data
Description: These data are usually measured continuously (monitoring of the resuscitation patient) and recorded on recorded on the resuscitation software.
Study NCT05032521 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment
Description: usual management based on the use of drugs according to international recommendations
Study NCT05032521 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stratified treatment according to algorithm
Description: management based on arteriovenous CO2 gradient Stratification of drug use
Study NCT05690373 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic effect on influenza vaccine response
Description: Seroconversion rate: the percentage of subjects achieving at least a 4-fold increase or an increase from >10 to 40 in Ab titre for seronegative subjects.
Study NCT04741932 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dementia Care Management (DCM)
Description: A computerized Information and Care Management System (IMS) will identify unmet nursing, medical, psychosocial and social needs of the PwD and its informal caregiver. Based on this data, the IMS generates suggestions for interventions: The DCM in cooperation with the general practitioner (GP) develops an individual treatment and care plan that is tailored to the needs of the PwD and its caregiver. The DCM will initiate the implementation of respective actions and monitor the status of implementation. Therefore, the DCMs are supposed to take on activities that were previously usually performed by doctors (redistribution of tasks between physicians and qualified nurses in primary care).
Study NCT04258852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low strength nicotine e-liquid
Description: Low strength nicotine e-liquid
Study NCT04258852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High strength nicotine e-liquid
Description: High strength nicotine e-liquid
Study NCT04859998 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: dog-assisted therapy
Description: It will consist of 20 sessions conducted twice a week in the facilities of the association. It will involve different activities and physical exercises facilitated by the dogs. The program will be conducted in two associations (12 participants in each one, 6 belonging to the experimental and 6 belonging to the control group in each association) and in groups of three participants.
Study NCT06084663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apremilast 30 mg Tablets
Description: Each film-coated tablet contains 30 mg of apremilast
Study NCT06084663 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Apremilast 30 mg Tablets
Description: Each film-coated tablet contains 30 mg of apremilast
Study NCT06084663 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Otezla 30 mg film-coated tablets
Description: Each film-coated tablet contains 30 mg of apremilast
Study NCT06084663 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Otezla 30 mg film-coated tablets
Description: Each film-coated tablet contains 30 mg of apremilast
Study NCT04959903 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Allogeneic T cell progenitors, cultured ex-vivo
Description: Injection of T cell progenitors at \[Day 4-Day 10\] after T cell depleted allogeneic HSCT
Study NCT05009095 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: The Listening Program® with bone conduction headphones
Description: The Listening Program method of Music-Based Auditory Stimulation is enhanced with the addition of bone conduction technology with the ABT Bone Conduction System. Bone Conduction combines the experience of listening to music through modified headphones adding subtle, synchronized acoustic vibration of the skin and skeletal system, engaging the whole body and brain in the listening process. This multi-sensory approach accelerates and expands the benefits of The Listening Program.
Study NCT06235294 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Resveratrol
Description: Daily capsule of 200 mg Polygonum cuspidatum (Solgar®, Dietimport, Lisboa, Portugal) yielding 100 mg/day resveratrol (trans-3,5,4'-trihydroxystilbene), by morning, every day during the 3 months preceding in vitro fertilization treatment.
Study NCT06235294 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Folic acid
Description: Daily capsule of 400 mcg folic acid (Solgar®, Dietimport, Lisboa, Portugal), by morning, every day during the 3 months preceding in vitro fertilization treatment.
Study NCT04921293 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Description: A diet with \<50gr of carbohydrates per day. Monosaturated fats consumption will encourage over saturated fats
Study NCT04921293 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Exogenous ketones
Description: Administration of ketone monoester 25 ml t.i.d